Department of Biochemical Engineering;
School of Chemical Engineering&Technology;
Tianjin University;
Tianjin 300350;
China;
Key Laboratory of Systems Bioengineering(Ministry of Education);
Tianjin University;
Tianjin 300072;
China;
Department of Gastroenterology;
Center of Tumor Immunology and Cytotherapy;
Medical Research Center of The Affiliated Hospital of Qingdao University;
Qingdao 266003;
China;
Department of Chemical and Biological Engineering;
University of Ottawa;
Ottawa KIN 6N5;
Canada;
Pancreatic cancer; nanobody therapeutic; intracellular antibody; HIF-1αinhibitor; gemcitabine; chemosensitizer;